Large-scale testing (Phase 3)Study completedNCT01045018
What this trial is testing
A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
Who this might be right for
Mild to Moderate Ulcerative Colitis
EMET Pharmaceuticals, LLC